Last updated: Oct 30, 2026, 12:00 AM

Intellia Therapeutics Inc Exchange (NASDAQ, USD)

NTLA

13.23
-0.09 (-0.68%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-5.23%
3 year return (CAGR)
-20.81%
5 year return (CAGR)
-37.08%
10 year return (CAGR)
0.48%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
1.85B
Price/Sales
31.15
Ent value
1.88B
Price/Book
2.55
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
9.70%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open13.32
Daily high13.94
Daily low12.91
Daily Volume4.69M
All-time high176.78
1y analyst estimate24.00
Beta1.82
EPS (TTM)-3.00
Dividend per share0.00
Ex-div date-
Next earnings date19 Feb 2026

Ready to capitalize on Intellia Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
NTLAS&P500
Current price drop from All-time high-92.52%-1.25%
Highest price drop-96.45%-56.47%
Date of highest drop8 Apr 20259 Mar 2009
Avg drop from high-58.41%-10.65%
Avg time to new high63 days12 days
Max time to new high1294 days1805 days